Do you have bladder cancer that has spread to nearby tissue or other parts of the body? You may be able to participate in a research study to find out if the investigational drug disitamab vedotin alone or with pembrolizumab works to treat bladder cancer.

Do you have Stage III or Stage IV Non-Small Cell Lung Cancer? Do you have a KRAS G12C mutation or are you interested in testing for this? If so, you may be able to participate in a study to see if adding a new medicine is more effective at controlling your cancer than the usual treatments.

The purpose of this research study is to investigate how human interpret some predictive learned by AI systems when detecting deceptive hotel reviews and how AI explanations can shape human understanding. For instance, the AI system learns that words like "floor" and "bathroom" are highly predictive of genuine reviews and words like "husband" and "luxury" are highly predictive of deceptive reviews. While the AI system highlights these words by learning from the data, the association between these words and the outcome are not easy to comprehend for humans. Thus, our goal of this research is to investigate how participants interact with machine-generated explanations that are unintuitive, and how participants make use of our developed visualizations and tools to make sense of these unintuitive features.

Have you been diagnosed with Multiple Myeloma? Have you received idecabtagene vicleucel (ide-cel (Abecma)) CAR-T treatment? If so, you may be able to take part in a research study looking at for how long a new drug called iberdomide will keep Multiple Myeloma under control (in remission).

This study aims to understand how a person's race and where they live affect the quality of breast cancer care they receive. We invite Black and/or African American breast cancer patients and survivors from specific areas of North Carolina to participate in a virtual focus group. The purpose of this focus group is to get your feedback about maps and other tools our team has created to show how breast cancer care quality varies around the state and by race. We also want to hear your experiences seeking care in your area, and your ideas about possible reasons behind the patterns in your area.

Have you been diagnosed with large B-cell lymphoma (LBCL) and have not yet received treament? If so, you may be able to take part in a research study looking at the efficacy of giving a drug called glofitamab in combination with other drugs. The drugs are: polatuzumab vedotin (Pola) (also known as Polivy→) and rituximab (R) (also known as Rituxan→ and MabThera→), as well as a group of chemotherapy drugs, cyclophosphamide (C), doxorubicin (H), and prednisone (P) (referred to as Pola-R-CHP).

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

Focus groups for adolescents and caregivers who have had eating disorders or disordered eating to help us develop a new treatment that is appropriate for members of the Latinx community.

In this study, we will look at how clinics give care to patients of all body sizes. We will talk to doctors and clinic staff to find out their policies and how they provide care that includes everyone.

Collect Biospecimens from subjects who are newly diagnosed with Acute Myeloid Leukemia (AML)